advertisement
Retina (Philadelphia, Pa.) 41
Showing records 1 to 25 | Display all abstracts in Retina (Philadelphia, Pa.)126450 INTRAVITREAL SUSTAINED RELEASE STEROID IMPLANTS ARE SAFE AND EFFECTIVE IN PATIENTS WITH GLAUCOMA DRAINAGE DEVICES
Zhou HW
Retina (Philadelphia, Pa.) 2025; 45: 877-882
125509 Outcomes of Persistent Exudative Retinal Detachments Following Proton Beam Irradiation for Choroidal Melanoma
Steinkerchner MS
Retina (Philadelphia, Pa.) 2025; 0:
125754 Visual outcomes and adherence challenges in proliferative diabetic retinopathy anti-VEGF monotherapy in the clinical practice setting
Maturi JR
Retina (Philadelphia, Pa.) 2025; 0:
125911 OPTIC PITLIKE MACULOPATHY WITH CLINICALLY OCCULT OPTIC DISK PIT DIAGNOSTIC IMAGING, CLINICAL FEATURES, AND MANAGEMENT
Shukla D
Retina (Philadelphia, Pa.) 2025; 45: 961-970
125657 INCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS
Patel NA
Retina (Philadelphia, Pa.) 2025; 45: 141-146
125820 Trends in Choroidal Vascularity Index in Cognitively Normal Individuals
Thompson C
Retina (Philadelphia, Pa.) 2025; 0:
125657 INCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS
Hoyek S; Hoyek S
Retina (Philadelphia, Pa.) 2025; 45: 141-146
125820 Trends in Choroidal Vascularity Index in Cognitively Normal Individuals
Lindeke-Myers A
Retina (Philadelphia, Pa.) 2025; 0:
126450 INTRAVITREAL SUSTAINED RELEASE STEROID IMPLANTS ARE SAFE AND EFFECTIVE IN PATIENTS WITH GLAUCOMA DRAINAGE DEVICES
Tandias R
Retina (Philadelphia, Pa.) 2025; 45: 877-882
125657 INCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS
Hoyek S
Retina (Philadelphia, Pa.) 2025; 45: 141-146
125509 Outcomes of Persistent Exudative Retinal Detachments Following Proton Beam Irradiation for Choroidal Melanoma
Lane AM
Retina (Philadelphia, Pa.) 2025; 0:
125754 Visual outcomes and adherence challenges in proliferative diabetic retinopathy anti-VEGF monotherapy in the clinical practice setting
Boucher N
Retina (Philadelphia, Pa.) 2025; 0:
125911 OPTIC PITLIKE MACULOPATHY WITH CLINICALLY OCCULT OPTIC DISK PIT DIAGNOSTIC IMAGING, CLINICAL FEATURES, AND MANAGEMENT
Kalliath J
Retina (Philadelphia, Pa.) 2025; 45: 961-970
125820 Trends in Choroidal Vascularity Index in Cognitively Normal Individuals
Zhao W
Retina (Philadelphia, Pa.) 2025; 0:
126450 INTRAVITREAL SUSTAINED RELEASE STEROID IMPLANTS ARE SAFE AND EFFECTIVE IN PATIENTS WITH GLAUCOMA DRAINAGE DEVICES
Lu ES
Retina (Philadelphia, Pa.) 2025; 45: 877-882
125657 INCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS
López-Font FJ
Retina (Philadelphia, Pa.) 2025; 45: 141-146
125509 Outcomes of Persistent Exudative Retinal Detachments Following Proton Beam Irradiation for Choroidal Melanoma
Gragoudas ES
Retina (Philadelphia, Pa.) 2025; 0:
125754 Visual outcomes and adherence challenges in proliferative diabetic retinopathy anti-VEGF monotherapy in the clinical practice setting
Fernando R
Retina (Philadelphia, Pa.) 2025; 0:
125911 OPTIC PITLIKE MACULOPATHY WITH CLINICALLY OCCULT OPTIC DISK PIT DIAGNOSTIC IMAGING, CLINICAL FEATURES, AND MANAGEMENT
Dhawan A
Retina (Philadelphia, Pa.) 2025; 45: 961-970
125820 Trends in Choroidal Vascularity Index in Cognitively Normal Individuals
Woo J
Retina (Philadelphia, Pa.) 2025; 0:
126450 INTRAVITREAL SUSTAINED RELEASE STEROID IMPLANTS ARE SAFE AND EFFECTIVE IN PATIENTS WITH GLAUCOMA DRAINAGE DEVICES
Hoyek S
Retina (Philadelphia, Pa.) 2025; 45: 877-882
125657 INCIDENCE OF STEROID-RELATED OCULAR HYPERTENSION AND CATARACT FORMATION AFTER SUB-TENON TRIAMCINOLONE IN NONUVEITIC PEDIATRIC PATIENTS
Shah S
Retina (Philadelphia, Pa.) 2025; 45: 141-146
125509 Outcomes of Persistent Exudative Retinal Detachments Following Proton Beam Irradiation for Choroidal Melanoma
Kim IK
Retina (Philadelphia, Pa.) 2025; 0:
125754 Visual outcomes and adherence challenges in proliferative diabetic retinopathy anti-VEGF monotherapy in the clinical practice setting
Scott AW
Retina (Philadelphia, Pa.) 2025; 0:
125911 OPTIC PITLIKE MACULOPATHY WITH CLINICALLY OCCULT OPTIC DISK PIT DIAGNOSTIC IMAGING, CLINICAL FEATURES, AND MANAGEMENT
Retina (Philadelphia, Pa.) 2025; 45: 961-970
